Anti-OSCP1/ C1orf102/ NOR1 monoclonal antibody

Anti-OSCP1/ C1orf102/ NOR1 antibody for FACS & in-vivo assay

Target products collectionGo to OSCP1/OSCP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2225-Ab-1/ GM-Tg-hg-MP2225-Ab-2Anti-Human OSCP1 monoclonal antibodyHuman
GM-Tg-rg-MP2225-Ab-1/ GM-Tg-rg-MP2225-Ab-2Anti-Rat OSCP1 monoclonal antibodyRat
GM-Tg-mg-MP2225-Ab-1/ GM-Tg-mg-MP2225-Ab-2Anti-Mouse OSCP1 monoclonal antibodyMouse
GM-Tg-cynog-MP2225-Ab-1/ GM-Tg-cynog-MP2225-Ab-2Anti-Cynomolgus/ Rhesus macaque OSCP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2225-Ab-1/ GM-Tg-felg-MP2225-Ab-2Anti-Feline OSCP1 monoclonal antibodyFeline
GM-Tg-cang-MP2225-Ab-1/ GM-Tg-cang-MP2225-Ab-2Anti-Canine OSCP1 monoclonal antibodyCanine
GM-Tg-bovg-MP2225-Ab-1/ GM-Tg-bovg-MP2225-Ab-2Anti-Bovine OSCP1 monoclonal antibodyBovine
GM-Tg-equg-MP2225-Ab-1/ GM-Tg-equg-MP2225-Ab-2Anti-Equine OSCP1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2225-Ab-1/ GM-Tg-hg-MP2225-Ab-2; GM-Tg-rg-MP2225-Ab-1/ GM-Tg-rg-MP2225-Ab-2;
GM-Tg-mg-MP2225-Ab-1/ GM-Tg-mg-MP2225-Ab-2; GM-Tg-cynog-MP2225-Ab-1/ GM-Tg-cynog-MP2225-Ab-2;
GM-Tg-felg-MP2225-Ab-1/ GM-Tg-felg-MP2225-Ab-2; GM-Tg-cang-MP2225-Ab-1/ GM-Tg-cang-MP2225-Ab-2;
GM-Tg-bovg-MP2225-Ab-1/ GM-Tg-bovg-MP2225-Ab-2; GM-Tg-equg-MP2225-Ab-1/ GM-Tg-equg-MP2225-Ab-2
Products NameAnti-OSCP1 monoclonal antibody
Formatmab
Target NameOSCP1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OSCP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species OSCP1/ C1orf102/ NOR1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2225
    Target NameOSCP1
    Gene ID127700,230751,362595,641439,475334,101087852,504974,100054927
    Gene Symbol and Synonyms1810007P19Rik,5730415O04,6030436A01Rik,C1orf102,NOR1,OSCP1,RGD1306596
    Uniprot AccessionQ8WVF1,Q4QQS3,Q29S00
    Uniprot Entry NameOSCP1_HUMAN,OSCP1_RAT,OSCP1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000116885
    Target ClassificationN/A

    The target: OSCP1, gene name: OSCP1, also named as C1orf102, NOR1. Enables transmembrane transporter activity. Involved in xenobiotic detoxification by transmembrane export across the plasma membrane. Located in basal plasma membrane and cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.